Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SVP, Chief Accounting Officer

CFO & COO

CFO and COO

Chief Accounting Officer

President and CEO

Chief Medical Officer

Chief Financial Officer

Chief Executive Officer

Pyxis Oncology, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody, which is in Phase 1 clinical trial for the treatment of solid tumors, including non-small cell lung cancer (NSCLC) without driver mutations/translocations, breast cancer, endometrial cancer, thyroid cancer, kidney cancer, cholangiocarcinoma, bladder cancer, colorectal cancer, and head and neck squamous cell carcinoma. The company's antibody drug conjugate product candidate is PYX-201, an investigational human immunoglobulin G1 isotype site-specifically conjugated, which is in Phase 1 clinical trial for solid tumors, including NSCLC, hormone receptor-positive breast cancer, ovarian cancer, thyroid cancer, pancreatic ductal adenocarcinoma, soft tissue sarcoma, hepatocellular carcinoma, and kidney cancer. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Pyxis Oncology, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies to treat cancers.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-26	Premium	acquired	Premium	Premium	Premium	-
2024-03-26	Premium	acquired	Premium	Premium	Premium	-
2024-03-26	Premium	acquired	Premium	Premium	Premium	-
2024-03-26	Premium	acquired	Premium	Premium	Premium	SVP, Chief Accounting Officer
2024-03-26	Premium	acquired	Premium	Premium	Premium	CFO & COO
2024-03-26	Premium	acquired	Premium	Premium	Premium	-
2024-03-26	Premium	acquired	Premium	Premium	Premium	-
2023-11-29	Premium	sold (taxes)	Premium	Premium	Premium	CFO and COO
2023-11-15	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-09-28	Premium	bought	Premium	Premium	Premium	CFO and COO
2023-09-27	Premium	bought	Premium	Premium	Premium	CFO and COO
2023-09-27	Premium	bought	Premium	Premium	Premium	Chief Accounting Officer
2023-09-25	Premium	bought	Premium	Premium	Premium	CFO and COO
2023-09-25	Premium	bought	Premium	Premium	Premium	Chief Accounting Officer
2023-09-22	Premium	bought	Premium	Premium	Premium	Chief Accounting Officer
2023-09-22	Premium	bought	Premium	Premium	Premium	CFO and COO
2023-09-18	Premium	sold	Premium	Premium	Premium	President and CEO
2023-09-14	Premium	sold	Premium	Premium	Premium	President and CEO
2023-09-13	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2023-09-13	Premium	sold	Premium	Premium	Premium	President and CEO
2023-09-12	Premium	sold	Premium	Premium	Premium	President and CEO
2023-09-11	Premium	sold	Premium	Premium	Premium	President and CEO
2023-09-07	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-09-07	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-09-07	Premium	acquired	Premium	Premium	Premium	CFO and COO

PYXS - Pyxis Oncology, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for PYXS